Successful treatment of life-threatening bleeding after cesarean section with recombinant activated factor VII

Clinical and Applied Thrombosis/Hemostasis

Volumn 12, Issue 2, 2006, Pages 227-229

  Heilmann, L ^a   Wild, C ^a   Hojnacki, B ^a   Pollow, K ^b  

^a Gesundheits und Pflegezentrum Russelsheim   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Emergency cesarean section; Postpartum bleeding; Recombinant activated factor VII; rFVIIa

Indexed keywords

DESMOPRESSIN; FRESH FROZEN PLASMA; PROSTAGLANDIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; UTEROTONIC AGENT; BLOOD CLOTTING FACTOR 7; RECOMBINANT FVIIA; RECOMBINANT PROTEIN;

ADULT; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; CESAREAN SECTION; CLINICAL EFFECTIVENESS; CONSERVATIVE TREATMENT; EMERGENCY SURGERY; ERYTHROCYTE TRANSFUSION; FEMALE; HEMATOMA; HEMORRHAGIC SHOCK; HEMOSTASIS; HUMAN; LAPAROTOMY; NULLIPARA; POSTOPERATIVE COMPLICATION; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; REOPERATION; THERAPY EFFECT; TREATMENT FAILURE; TREATMENT OUTCOME; UTERUS BLEEDING; VAGINA BLEEDING; CRITICAL ILLNESS; PREGNANCY;

ADULT; CESAREAN SECTION; CRITICAL ILLNESS; FACTOR VII; FEMALE; HUMANS; POSTPARTUM HEMORRHAGE; PREGNANCY; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 33747781102     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960601200213     Document Type: Article

References (9)

1. Bouwmeester FW, Jonkhoff AR, Verheijen RHM, van Geijn HP. Successful treatment of life threatening postpartum hemorrhage with recombinant activated factor VII. Obstet Gynecol 2003;101:1174.
2. Branch DW, Rodgers GM. Recombinant activated factor VII: A new weapon in the fight against hemorrhage. Obstet Gynecol 2003;101:1155.
3. Breborowicz GH, Sobiewszszyk S, Symankiewicz M. Efficacy of recombinant factor VII (rFVIIa, NovoSeven) in prenatal medicine. Arch Perinat Med 2002;8:21.
4. Bukowski R, Hankins GDV. Managing postpartum hemorrhage. Contemp Obstet Gynecol 2001;9:92.
5. Heuer L, Blumenberg D. Recombinant factor VIIa(NovoSeven). A review of current and possible future indications. Anaesthesist 2002;51:388.
6. Lisman T, de Groot PHG. Mechanism of action of recombinant factor VIIa. J Thromb Haemost 2003;1:1138.
7. Moscardo F, Perez F, delaRubia J, et al. Successful treatment of severe intraabdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. Br J Haematol 2001;113:174.
8. Stones RW, Paterson CM, Saunders NJ. Risk-factors for major obstetric haemorrhage. Eur J Reprod Biol 1993;48:15.
9. Zupancic-Salek S, Sokolic V, Viskovic T, et al. Successful use of recombinant factor VIIa for massive bleeding after cesarean section due to HELLP-Syndrome. Acta Haematol 2002;108:162.